(Q54232902)

26 May 2018

title

Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. (English)

1 reference

26 May 2018

1 reference

1

1 reference

26 May 2018

Michael Gnant

8

1 reference

26 May 2018

author name string

Monika Artl

2

1 reference

26 May 2018

Martin Filipits

3

1 reference

26 May 2018

Margit Resel

4

1 reference

26 May 2018

Ricarda Graf

5

1 reference

26 May 2018

Bettina Weißenbacher

6

1 reference

26 May 2018

Sigurd Lax

7

1 reference

26 May 2018

Fritz Wrba

9

1 reference

26 May 2018

Richard Greil

10

1 reference

26 May 2018

Otto Dietze

11

1 reference

26 May 2018

Friedrich Hofbauer

12

1 reference

26 May 2018

Gerhard Böhm

13

1 reference

26 May 2018

Gerald Höfler

14

1 reference

26 May 2018

Hellmut Samonigg

15

1 reference

26 May 2018

Renate Schaberl-Moser

16

1 reference

26 May 2018

Marija Balic

17

1 reference

26 May 2018

Nadia Dandachi

18

1 reference

26 May 2018

publication date

6 December 2013

1 reference

26 May 2018

published in

Modern Pathology

1 reference

26 May 2018

volume

27

1 reference

26 May 2018

issue

6

1 reference

26 May 2018

page(s)

906-915

1 reference

26 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2013.204

exact match

0 references

cites work

Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Genetic and epigenetic traits as biomarkers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Systematic review of microsatellite instability and colorectal cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Thymidylate synthase expression and prognosis in colorectal cancer: a meta-analysis of colorectal cancer survival data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Epigenetic biomarkers in colorectal cancer diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Epigenetics and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

CpG island methylator phenotype in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Cadherins and cancer: how does cadherin dysfunction promote tumor progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Clinical and prognostic significance of protocadherin-10 (PCDH10) promoter methylation in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Identification of SPARC as a candidate target antigen for immunotherapy of various cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Frequent inactivation of SPARC by promoter hypermethylation in colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Secreted protein acidic and rich in cysteine-induced cellular senescence in colorectal cancers in response to irinotecan is mediated by P53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Ubiquitin C-terminal hydrolase l1 in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Neurogenesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Relevance, pathogenesis, and testing algorithm for mismatch repair-defective colorectal carcinomas: a report of the association for molecular pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

Patterns of metastasis in human solid cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

7 January 2021

DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

7 January 2021

BAGE hypomethylation, a new epigenetic biomarker for colon cancer detection

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

7 January 2021

The clinical significance of PCDH10 promoter methylation in patients with bladder transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

7 January 2021

Significance of PGP9.5 expression in cancer-associated fibroblasts for prognosis of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

7 January 2021

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.204

7 January 2021

10.1038/MODPATHOL.2013.204

Identifiers

DOI

1 reference

26 May 2018

1 reference

26 May 2018